Considerations in Initiating Genomic Screening Programs in Health Care Systems

While genomic information has been used to identify disease risk and select treatments for individuals with a clinical or family history of a condition with a major genetic component, genomic disease risk screening for conditions such as hereditary breast and ovarian cancer, Lynch syndrome, or familial hyper cholesterolemia is now being considered for surveillance of unselected populations in health care systems and public health programs (Modell,  Greendale, Citrin,& Kardia, 2016). Clinical nurses and nurse scientists have a large role to play in the future of genomic screening in health systems including developing pragmatic clinical trials using screening data, interrogating biologic pathways, providing patient education and assessing patient understanding, and supporting family communication of findings.

Source: Nursing Outlook - July 12, 2018 Category: Nursing Authors: Janet K. Williams, W. Gregory Feero, David L. Veenstra, Angela Starkweather, Ann K. Cashion Source Type: research